Content about Flemish people

May 23, 2013

Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.

NEW BRUNSWICK, N.J. — Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.

J&J's Janssen Pharmaceutical Cos. highlighted its more than 11 new product launches since 2009 and said it hoped to file with the FDA for more than two-dozen "significant" extensions to its branded drug lines by 2017.

April 24, 2013

Johnson & Johnson subsidiary Janssen has launched an interactive educational website about diabetes for European healthcare professionals.

BEERSE, Belgium — Johnson & Johnson subsidiary Janssen has launched an interactive educational website about diabetes for European healthcare professionals.

Dubbed the Janssen Diabetes Forum, the website is designed to educate users about the latest developments in the management of Type 2 diabetes. The website was launched Tuesday in Beerse, Belgium.

September 30, 2010

Shareholders of Belgian drug maker Movetis have put up nearly all of their shares for...

DUBLIN Shareholders of Belgian drug maker Movetis have put up nearly all of their shares for sale as British drug maker Shire moves to acquire the company, Shire said Thursday.

 

Shire said 99.18% of Movetis’ shares had been tendered as of Monday.

 

 

Shire announced last month that it would buy Movetis for $567 million. The Turnhout, Belgium-based company makes gastroenterology drugs.

 

August 8, 2010

British drug maker Shire will acquire Belgian drug maker Movetis for $567 million, Movetis said....